Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups-Reference-Cited by-同舟云学术

Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups

Published:2020-12 Issue:5 Volume:108 Page:1204-1217
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Carrie Christian,Kieffer Virginie,Figarella-Branger Dominique,Masliah-Planchon Julien,Bolle Stéphanie,Bernier Valérie,Laprie Anne,Supiot Stéphane,Leseur Julie,Habrand Jean-Louis,Alapetite Claire,Kerr Christine,Dufour Christelle,Claude Line,Chapet Sophie,Huchet Aymeri,Bondiau Pierre-Yves,Escande Alexandre,Truc Gilles,Nguyen Tan Dat,Pasteuris Caroline,Vigneron Céline,Muracciole Xavier,Bourdeaut Franck,Appay Romain,Dubray Bernard,Colin Carole,Ferlay Céline,Dussart Sophie,Chabaud Sylvie,Padovani Laetitia

Funder

French Health Ministry

La Ligue de Haute-Savoie

Electricité de France–Le Commissariat de l’Energie Atomique

Société Française des cancers de l’enfant

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference43 articles.

1. Radiotherapy for medulloblastoma in children: A perspective on current international clinical research efforts;Freeman;Med Pediatr Oncol,2002

2. The potential impact of tumor biology on improved clinical practice for medulloblastoma: Progress toward biologically driven clinical trials;Pizer;Br J Neurosurg,2009